Moderate riskFDA DrugClass II

McKesson gemcitabine injection recalled for improper storage

One lot of McKesson gemcitabine injection, a single-dose vial for intravenous infusion, was stored at controlled room temperature instead of in a refrigerator. The recall covers 74 units of lot CB0046. No injuries have been reported.

From the FDA notice · Read the official notice ↗

What to do

  1. Set aside any vials from lot CB0046 (exp. 06/2027) and do not administer them.
  2. Check the NDC on vial labels: 0143-9341-01 identifies the product.
  3. The notice doesn't say how to get a replacement or refund; contact McKesson or Hikma.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Gemcitabine Injection, 1 g per 26.3 mL (38 mg/mL), 26.3 mL Single-Dose Vial, For Intravenous Infusion ONLY, Rx only, Manufactured by: THYMOORGAN PHARMAZIE GmbH, Schiffgraben 23, 38690 Goslar, Germany; Distributed by: Hikma, Berkeley Heights, NJ 07922. NDC: 0143-9341-01
Sold in
Nationwide
Made for
All ages (0 months and older)

Details

Units affected
74 units
Illnesses reported
None reported
Manufactured in
6555 State Highway 161, N/A, Irving, TX, United States
Classification
Class II
Recall number
D-0714-2026

In the FDA's words

Description
Gemcitabine Injection, 1 g per 26.3 mL (38 mg/mL), 26.3 mL Single-Dose Vial, For Intravenous Infusion ONLY, Rx only, Manufactured by: THYMOORGAN PHARMAZIE GmbH, Schiffgraben 23, 38690 Goslar, Germany; Distributed by: Hikma, Berkeley Heights, NJ 07922. NDC: 0143-9341-01 Temperature Abuse: Product was stored incorrectly in a controlled room temperature environment instead of a refrigerated environment. Lot #: CB0046, Exp. Date 06/2027 Distribution: Nationwide within the United States Affected quantity: 74 units
Hazard
Temperature Abuse: Product was stored incorrectly in a controlled room temperature environment instead of a refrigerated environment.

Related topics

PotencySterilityDrugsSold nationwideMore from FDA Drug